Expression of Cyclooxygenase-2 in Human Breast Carcinoma: Relevance to Tumor Angiogenesis and Expression of Estrogen Receptor.

No abstract is available for this paper.

• Publication year

  2001

• Venue

  Cancer research and treatment : official journal of Korean Cancer Association

• Publication date

  2001-08-31

• Fields of study

  Medicine

• Identifiers
  DOI 10.4143/crt.2001.33.4.286PMID 26680798
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Optimizing microvessel counts according to tumor zone in invasive ductal carcinoma of the breast.

  1999cited by this paper
• Cyclooxygenase inhibitors suppress angiogenesis and reduce tumor growth in vivo.

  1999influential reference
• Correlation of aromatase and cyclooxygenase gene expression in human breast cancer specimens.

  1999cited by this paper
• Angiogenesis as a prognostic marker in breast carcinoma with conventional adjuvant chemotherapy: a multiparametric and immunohistochemical analysis

  1998influential reference
• Expression of cyclooxygenase-1 and cyclooxygenase-2 in human breast cancer.

  1998cited by this paper
• Patterns and Emerging Mechanisms Review of the Angiogenic Switch during Tumorigenesis

  1996cited by this paper
• Differential expression and regulation of cyclooxygenase-1 and -2 in two human breast cancer cell lines.

  1996cited by this paper
• [Recommendations for the immunohistochemical evaluation of hormone receptors on paraffin sections of breast cancer. Study Group on Hormone Receptors using Immunohistochemistry FNCLCC/AFAQAP. National Federation of Centres to Combat Cancer/French Association for Quality Assurance in Pathology].

  1996cited by this paper
• Section Review Oncologic, Endocrine & Metabolic: Angiogenesis inhibition as a drug target for disease: an update

  1996cited by this paper
• Alterations in cellular adhesion and apoptosis in epithelial cells overexpressing prostaglandin endoperoxide synthase 2.

  1995cited by this paper
• Assessment of angiogenesis in breast carcinoma: an important factor in prognosis?

  1995cited by this paper
• Towards a better aspirin

  1994cited by this paper
• Expression of the protein product of the prostaglandin synthase-2/TIS10 gene in mitogen-stimulated Swiss 3T3 cells.

  1993cited by this paper
• Aspirin use and reduced risk of fatal colon cancer.

  1991cited by this paper
• Persistent induction of cyclooxygenase in p60v-src-transformed 3T3 fibroblasts.

  1990cited by this paper
• ALTERATIONS IN THE

  1985cited by this paper
• Relationships of prostaglandin E and natural killer sensitivity to metastatic potential in murine mammary adenocarcinomas.

  1985cited by this paper
• Do hormones cause breast cancer?

  1984cited by this paper
• Breast cancer, its recurrence, and patient survival in relation to tumor prostaglandins.

  1983cited by this paper
• Prostaglandins in breast cancer: relationship to disease stage and hormone status.

  1983cited by this paper
• Hormone dependence of 7,12-dimethylbenz[a]anthracene-induced mammary tumor growth: correlation with prostaglandin E2 content.

  1982influential reference
• Prostaglandin in human breast cancer: Evidence suggesting that an elevated prostaglandin production is a marker of high metastatic potential for neoplastic cells.

  1980cited by this paper
• Breast-cancer osteolysis, bone metastases, and anti-osteolytic effect of aspirin.

  1976cited by this paper

• Molecular Docking and Dynamics Simulation Analyses of Ibuprofen Derivatives as Potential Anti-Cancer Agents Targeting COX-2

  2025cites this paper
• Hormone Receptor Signaling and Breast Cancer Resistance to Anti-Tumor Immunity

  2023cites this paper
• Molecular targets of HPV oncoproteins: potential biomarkers for cervical carcinogenesis.

  2014cites this paper
• Clinicopathologic Implications of the Epidermal Growth Factor Receptor, Cyclooxygenase 2 Expression, and Human Papillomavirus Status in Squamous Cell Carcinoma of the Uterine Cervix in the Elderly

  2010cites this paper
• Expression of C yclooxygenase-2 in H um an Breast C ancer: Relationship w ith H ER-2/neu and other C linicopathological Prognostic Factors

  2009cites this paper
• M icrovessel Density in Invasive Breast Carcinoma-Comparison A nalysis w ith Clinico-pathological Param eters

  2009cites this paper
• M ast C ell and M acro phage C ou nts and M icro vessel D ensity in Invasive Breast C arcinom a-C om parison A naly sis w ith C linico - patho lo gical Param eters

  2005cites this paper
• Mast cell and macrophage counts and microvessel density in invasive breast carcinoma-comparison analysis with clinicopathological parameters.

  2005cites this paper
• Coexpression of cyclooxygenase-2 and thymidine phosphorylase as a prognostic indicator in patients with FIGO stage IIB squamous cell carcinoma of uterine cervix treated with radiotherapy and concurrent chemotherapy.

  2005cites this paper
• Expression of cyclooxygenase-2 in human breast cancer: relationship with HER-2/neu and other clinicopathological prognostic factors.

  2005cites this paper
• Clinical value of cyclooxygenase-2 expression in human breast carcinoma.

  2004cites this paper
• Synchronous Coexpression of Epidermal Growth Factor Receptor and Cyclooxygenase-2 in Carcinomas of the Uterine Cervix

  2004cites this paper
• Cyclooxygenase-2: a potential target in human cancer.

  2004cites this paper
• Uterine Cervix: A Potential Predictor of Poor Survival Receptor and Cyclooxygenase-2 in Carcinomas of the Synchronous Coexpression of Epidermal Growth Factor

  2004cites this paper
• Expression of cyclooxygenase (COX)-2 as a prognostic factor in nasopharyngeal cancer.

  2004cites this paper
• Overexpression of cyclooxygenase‐2 is associated with a poor prognosis in patients with squamous cell carcinoma of the uterine cervix treated with radiation and concurrent chemotherapy

  2002cites this paper